Insider Stock Trading History of Wyzga Michael S


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Wyzga Michael S since year 2005. The trader's CIK number is 1201256. At the time of this reporting, Wyzga Michael S is the Executive VP and CFO of Akebia Therapeutics, Inc. . (stock ticker symbol AKBA). See this page for all insider trading activities at Akebia Therapeutics, Inc. .

Note that in the past WYZGA MICHAEL S also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Wyzga Michael S since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-03-25 AKBA Akebia Therapeutics, Inc. Buy 1,500 17.00 25,500
2011-04-04 GENZ Genzyme Corp Option Ex 29,250 .00 0
2010-05-24 GENZ Genzyme Corp Option Ex 15,000 .00 0
2010-05-25 GENZ Genzyme Corp Sale 5,068 45.63 231,252
2008-08-12 GENZ Genzyme Corp Sale 29,390 79.00 2,321,810
2008-08-12 GENZ Genzyme Corp Option Ex 29,390 35.51 1,043,727
2007-12-17 GENZ Genzyme Corp Sale 5,140 74.89 384,934
2007-12-17 GENZ Genzyme Corp Option Ex 5,140 43.36 222,870

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wyzga Michael S (Executive VP and CFO of Akebia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.